Diageo plc
86.10USD
-1.0400 (-1.19%)
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current year | $6.76▲ | $6.46 | 3 | 0 |
| Next year | $6.88▼ | $6.9 | 1 | 1 |
72 ratings from 32 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| TD Cowen | Upgraded from Hold | Buy | $88 $93 | Jun 26, 2026 |
| UBS | Downgraded from Buy | Neutral | — | Dec 3, 2025 |
| B of A Securities | Maintained | Buy | $117 $109 | Sep 26, 2025 |
| TD Cowen | Maintained | Hold | $124 $129 | Jan 8, 2025 |
| Jefferies | Upgraded from Hold | Buy | — | Dec 4, 2024 |
| Citigroup | Upgraded from Neutral | Buy | — | Jul 3, 2024 |
| Argus Research | Downgraded from Buy | Hold | — | Jan 4, 2024 |
| JP Morgan | Downgraded from Overweight | Neutral | — | Nov 29, 2023 |
| Morgan Stanley | Downgraded from Equal-Weight | Underweight | — | Jul 20, 2023 |
| Goldman Sachs | Downgraded from Buy | Neutral | $217.8 $186.48 | Jun 15, 2023 |
| Jefferies | Downgraded from Buy | Hold | — | May 12, 2023 |
| Bernstein | Upgraded from Market Perform | Outperform | $215 $225 | Feb 6, 2023 |
| Deutsche Bank | Downgraded from Hold | Sell | — | Jun 29, 2022 |
| JP Morgan | Upgraded from Neutral | Overweight | — | Mar 17, 2022 |
| RBC Capital | Downgraded from Sector Perform | Underperform | — | Dec 9, 2021 |
| Argus Research | Upgraded from Hold | Buy | $225 | Jun 4, 2021 |
| Morgan Stanley | Upgraded from Equal-Weight | Overweight | — | Nov 27, 2020 |
| Jefferies | Upgraded from Underperform | Buy | $109 $164 | Oct 7, 2020 |
| CFRA | Maintained | Hold | $166 $123 | May 26, 2020 |
| Goldman Sachs | Initiated | Buy | — | Feb 26, 2020 |
| CFRA | Maintained | Hold | $166 $175 | Feb 5, 2020 |
| Argus Research | Downgraded from Buy | Hold | — | Feb 4, 2020 |
| JP Morgan | Downgraded from Neutral | Underweight | — | Jan 28, 2020 |
| Bernstein | Upgraded from Underperform | Market Perform | — | Sep 10, 2019 |
| Goldman Sachs | Upgraded from Neutral | Buy | — | Jul 13, 2018 |
29 filings from 6 insiders · 0 buy / 0 sell over 6m
Officers and directors of DEO, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| Brooks (Hannah) | Other | 21 | $81.06 | $2k | Jun 11, 2026 |
| Grimes Sally | Other | 1 | $77.30 | $77 | Mar 17, 2026 |
| Grimes Sally | Other | 1 | — | — | Mar 17, 2026 |
| Brooks (Hannah) | Other | 773 | — | — | Mar 9, 2026 |
| Brooks (Hannah) | Sell | 321 | $81.25 | $26k | Mar 9, 2026 |
| Grimes Sally | Other | 1 | $88.19 | $88 | Jan 20, 2026 |
| Grimes Sally | Other | 1 | — | — | Jan 20, 2026 |
| Cardenas (Alvaro) | Other | 634 | — | — | Sep 2, 2025 |
| Cardenas (Alvaro) | Sell | 155 | $110.41 | $17k | Sep 2, 2025 |
| Cardenas (Alvaro) | Other | 938 | — | — | Sep 2, 2025 |
| Cardenas (Alvaro) | Sell | 229 | $110.41 | $25k | Sep 2, 2025 |
| Grimes Sally | Other | 1.9k | — | — | Sep 2, 2025 |
| Grimes Sally | Sell | 767 | $110.41 | $85k | Sep 2, 2025 |
| Kennedy (John) | Other | 6 | $124.21 | $745 | Oct 22, 2024 |
| Kennedy (John) | Other | 3 | $124.21 | $372 | Oct 21, 2024 |
| Kennedy (John) | Other | 3.1k | — | — | Sep 3, 2024 |
| Kennedy (John) | Sell | 3.1k | $129.11 | $394k | Sep 3, 2024 |
| Kennedy (John) | Other | 7.4k | — | — | Sep 3, 2024 |
| Kennedy (John) | Sell | 3.9k | $129.11 | $500k | Sep 3, 2024 |
| Kennedy (John) | Other | 6.1k | — | — | Sep 3, 2024 |
No analyst notes on DEO yet.
Analyst Ratings
7 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 0 | 4 | 3 | 1 | 0 | Hold2.63 |
| 1 mo ago | 1 | 4 | 2 | 1 | 0 | Buy2.38 |
| 2 mo ago | 1 | 4 | 2 | 1 | 0 | Buy2.38 |